Arbutus Biopharma Corp

Most Recent

  • uploads///pills _
    Company & Industry Overviews

    ContraVir Stock Rose on Clinical Trial Progress Report

    ContraVir Pharmaceuticals is focused on the development of antiviral therapies with a special focus on the development of anti-HBV therapies.

    By Daniel Collins
  • uploads///bacteria _
    Company & Industry Overviews

    Why Arbutus Biopharma Stock Plunged 24.4% Today

    Today, Arbutus Biopharma (ABUS) stock is trading at $6.87, which is a 24.42% decline from its October 8 closing price of $9.09.

    By Daniel Collins
  • uploads///red blood cells _
    Company & Industry Overviews

    Why Dicerna Pharmaceuticals Stock Rose 7.7% Yesterday

    On September 13, Dicerna Pharmaceuticals (DRNA) stock rose 7.71% to $16.62 from its previous day’s close of $15.43.

    By Daniel Collins
  • uploads///nucleotide _
    Company & Industry Overviews

    Why Arrowhead Pharmaceuticals Stock Is Skyrocketing Today

    Today, Arrowhead Pharmaceuticals (ARWR) stock is trading at $20.12, which represents ~42.7% growth from yesterday’s close of $14.10.

    By Daniel Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.